Is there any interaction of resistin and adiponectin levels with protein-energy wasting among patients with chronic kidney disease

Hemodialysis International

Volumn 18, Issue 1, 2014, Pages 153-162

  Kaynar, Kubra ^a   Kural, Birgul V ^a   Ulusoy, Sukru ^a   Cansiz, Muammer ^a   Akcan, Buket ^a   Misir, Nuray ^a   Yaman, Selcuk ^a   Kaya, Nuh ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Adiponectin; Chronic kidney disease; Ghrelin; Leptin; Protein energy wasting; Resistin

Indexed keywords

ADIPONECTIN; ALBUMIN; GHRELIN; LEPTIN; NEUROPEPTIDE Y; RESISTIN;

ADULT; ALBUMIN BLOOD LEVEL; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY FAT; BODY MASS; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HORMONE BLOOD LEVEL; HUMAN; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MIDUPPER ARM MUSCLE CIRCUMFERENCE; NUTRITIONAL ASSESSMENT; NUTRITIONAL DISORDER; PERITONEAL DIALYSIS; PROTEIN BLOOD LEVEL; PROTEIN ENERGY WASTING; PROTEIN INTAKE; SKINFOLD THICKNESS;

ADIPONECTIN; CHRONIC KIDNEY DISEASE; GHRELIN; LEPTIN; PROTEIN-ENERGY WASTING; RESISTIN;

ADIPONECTIN; ADULT; BASE SEQUENCE; FEMALE; GHRELIN; HUMANS; LEPTIN; MALE; MOLECULAR SEQUENCE DATA; NEUROPEPTIDE Y; NUTRITION ASSESSMENT; PERITONEAL DIALYSIS; PROTEIN DEFICIENCY; RENAL INSUFFICIENCY, CHRONIC; RESISTIN; WASTING SYNDROME; YOUNG ADULT;

EID: 84891901587     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/hdi.12072     Document Type: Article

References (30)

1. Fouque D, Kalantar-Zadeh K, Kopple J, etal. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008; 73:391-398.
2. Kalantar-Zadeh K, Kuwae N, Wu DY, etal. Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr. 2006; 83:202-210.
3. Carrero JJ, Chmielewski M, Axelsson J, etal. Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients. Clin Nutr. 2008; 27:557-564.
4. Bonanni A, Mannucci I, Verzola D, etal. Protein-energy wasting and mortality in chronic kidney disease. Int J Environ Res Public Health. 2011; 8:1631-1654.
5. Niemczyk S, Romejko-Ciepielewska K, Niemczyk L. Adipocytokines and sex hormone disorders in patients with chronic renal failure (CRF). Endokrynol Pol. 2012; 63:148-155.
6. Mak RH, Cheung WW. Is ghrelin a biomarker for mortality in end stage renal disease. Kidney Int. 2011; 79:697-699.
7. Daugirdas JT. Second generation logarithmic estimates of single pool variable volume Kt/V: An analysis of error. J Am Soc Nephrol. 1993; 4:1205-1213.
8. Lightfoot BO, Caruana RJ, Mulloy LL, Fincher ME. Simple formula for calculating normalized protein catabolic rate (nPCR) in hemodialysis (HD) patients (abstract). J Am Soc Nephrol. 1993; 4:363-363.
9. Tzamaloukas AH, Murata GH, Malhotra D, Sena P, Patron A. Urea kinetic modeling in continuous peritoneal dialysis patients. Effect of body composition on the methods for estimating urea volume of distribution. ASAIO J. 1993; 39:M359-M362.
10. Keshaviah PR, Nolph KD. Protein catabolic rate calculations in CAPD patients. ASAIO Trans. 1991; 37:M400-M402.
11. Van Acker BA, Koomen GC, Kopman MG, de Waart DR, Arisz L. Creatinine clearance during cimetidine administration for measurement of glomerular filtration rate. Lancet. 1992; 340:1326-1329.
12. Levey AS, Bosch JP, Lewis JB, Grene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130:461-470.
13. Dombros N, Dratwa M, Feriani M, etal. European Best Practice Guidelines for peritoneal dialysis.The initiation of dialysis. Nephrol Dial Transplant. 2005; 20(Suppl 9):3-7.
14. Maroni BJ, Steinman TI, Mitch WE. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int. 1985; 27:58-65.
15. Fouque D, Vennegoor M, Wee PT, etal. EBPG Guideline on nutrition. Nephrol Dial Transplant. 2007; 22(Suppl 2):45-87.
16. Durnin JV, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: Emasurements on 481 men and women aged from 16-72 yeras. Br J Nutr. 1974; 32:77-97.
17. WHO. Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000; 894:1-253.
18. Bishop CW, Bowen PE, Ritchey SJ. Norms for nutritional assessment of American adults for upper arm anthropometry. Am J Clin Nutr. 1981; 34:2530-2539.
19. Carrero JJ, Nakashima A, Qureshi AR, etal. Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patients. Kidney Int. 2011; 79:749-756.
20. Tschöp M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes. 2001; 50:707-709.
21. Ukkola O. Ghrelin and insulin metabolism. Eur J Clin Invest. 2003; 33:183-185.
22. Date Y, Kojima M, Hosoda H, etal. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology. 2000; 141:4255-4261.
23. Oner-Iyidogan Y, Gurdol F, Kocak H, etal. Appetite-regulating hormones in chronic disease patients. J Ren Nutr. 2011; 21:316-321.
24. Shiiya T, Nakazato M, Mizuta M, etal. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab. 2001; 87:240-244.
25. Yoshimoto A, Mori K, Sugawara A, etal. Plasma ghrelin and desacyl ghrelin concentrations in renal failure. J Am Soc Nephrol. 2002; 13:2748-2752.
26. Chudek J, Adamczak M, Nieszporek T, Wiecek A. The adipose tissue as an endocrine organ-a nephrologists' perspective. Contrib Nephrol. 2006; 151:70-90.
27. Kawamura R, Doi Y, Osawa H, etal. Circulating resistin is increased with decreasing renal function in a general Japanese population: The Hisayama Study. Nephrol Dial Transplant. 2010; 25:3236-3240.
28. Krzyzanowska-Swiniarska B, Kempa A, Miazgowski T, Pilarska K. Serum acylated ghrelin, adiponectin and leptin levels in normal-weight and obese premenopausal women. Horm Metab Res. 2007; 39:835-839.
29. Mak RH, Cheung W, Cone RD, Marks DL. Orexigenic and anorexigenic mechanisms in the control of nutrition in chronic kidney disease. Pediatr Nephrol. 2005; 20:427-431.
30. Daschner M, Tonshoff B, Blum WF, etal. Inappropriate elevation of serum leptin levels in children with chronic renal failure. European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. J Am Soc Nephrol. 1998; 9:1074-1079.